The subject of “omics”, such as in genomics, will be the focus of the next Council for Entrepreneurial Development’s next biotech panel discussion.

“The World of “Omics” – Technology Platforms — Paradigm Shift or Hype?” is set for Monday, Jan. 9, at the NC Biotechnology Center at 5:30 PM.

Panelists include Michael Murphy, chief executive officer of Gentris; Steve McPhail, CEO of Expression Analysis; and John Ryals, CEO of Metabolon. Will Lee, a scientist at Cato Research, will be the moderator.